Figure 2, represented below, demonstrates the differential expression of the four distinct proteins (namely HMGB1, SCCA/Serpin B3, CEA, and CYFRA 21-1/Cytokeratin 19) against HPV type 16, 18, and both 16+18 in cervical cancer patients. This evidence concerns the gene HMGB1 and cervical carcinoma.